Majority of AI clinical trials report positive outcomes, yet concerns over generalizability persist Post author: Post published:April 29, 2024 Post category:uncategorized The state of randomized controlled trials (RCTs) for artificial intelligence (AI) algorithms in clinical practice. You Might Also Like Esketamine outperforms one of the standard drugs for treatment-resistant major depression October 5, 2023 Amalus Therapeutics develops innovative approach for treating patients with cancer or fibrotic diseases November 20, 2023 New animation series launched to improve parental understanding of brain development in premature infants March 7, 2024
Esketamine outperforms one of the standard drugs for treatment-resistant major depression October 5, 2023
Amalus Therapeutics develops innovative approach for treating patients with cancer or fibrotic diseases November 20, 2023
New animation series launched to improve parental understanding of brain development in premature infants March 7, 2024